Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells
Renate Wagner(Medical University of Vienna), Thomas W. Grunt(Comprehensive Cancer Center Vienna)
Cited by 57
Related Papers
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells
|International Journal of Cancer|2014|62